Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) Equity Ratio (2016 - 2025)

ENDRA Life Sciences has reported Equity Ratio over the past 6 years, most recently at 0.84 for Q4 2021.

  • Quarterly Equity Ratio rose 2.41% to 0.84 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 0.84 through Dec 2021, up 2.41% year-over-year, with the annual reading at 0.84 for FY2021, 2.41% up from the prior year.
  • Equity Ratio was 0.84 for Q4 2021 at ENDRA Life Sciences, down from 0.86 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.98 in Q2 2017 and troughed at 2.53 in Q1 2017.
  • The 5-year median for Equity Ratio is 0.79 (2020), against an average of 0.52.
  • Year-over-year, Equity Ratio plummeted 136.96% in 2018 and then skyrocketed 209.53% in 2019.
  • A 5-year view of Equity Ratio shows it stood at 0.86 in 2017, then increased by 0.42% to 0.87 in 2018, then decreased by 23.31% to 0.66 in 2019, then increased by 23.3% to 0.82 in 2020, then grew by 2.41% to 0.84 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Equity Ratio are 0.84 (Q4 2021), 0.86 (Q3 2021), and 0.87 (Q2 2021).